Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger
January 12, 2015 at 15:44 PM EST
Speaking to Benzinga, Griffin Securities Analyst Dr. Keith Markey said that after MannKind Corporation (NASDAQ: MNKD) founder Alfred ...